The forecast of antibacterial medicine sales in Sweden for 2024 to 2028 shows a consistent year-on-year decline in US Dollars per capita. The data presents a gradual decrease from $6.8 in 2024 to $6.4 in 2028. This reflects an incremental annual reduction of approximately 1.47% per year. Noticeably, antibacterial medicine sales in 2023 stood at $6.9 per capita, marking a decrease in demand compared to previous years. Over the last two years, a negative growth trend emerges, with around a 1.45% decline from 2023 to 2024.
Key future trends to watch for include the impact of advancements in alternative treatments, heightened awareness about antibiotic resistance, and regulatory changes affecting antibacterial medicine usage. Monitoring these factors will be crucial for predicting future market dynamics.
